RELX Balance Sheet Health

Financial Health criteria checks 3/6

RELX has a total shareholder equity of £3.2B and total debt of £6.8B, which brings its debt-to-equity ratio to 214.6%. Its total assets and total liabilities are £14.7B and £11.5B respectively. RELX's EBIT is £2.8B making its interest coverage ratio 9.5. It has cash and short-term investments of £140.0M.

Key information

214.6%

Debt to equity ratio

UK£6.83b

Debt

Interest coverage ratio9.5x
CashUK£140.00m
EquityUK£3.18b
Total liabilitiesUK£11.53b
Total assetsUK£14.71b

Recent financial health updates

No updates

Recent updates

RELX PLC: I've Underestimated This Company

Aug 29

RELX: Business Remains Strong, But Now Looks Overvalued (Rating Downgrade)

Jun 04

RELX Q4: Strong Demand Momentum Should Sustain Current Organic Growth Pace

Feb 29

RELX: No Surprises

Feb 18

RELX: Eyes On Risk And Exhibitions Businesses

Dec 01

RELX: Taking A Breather (Rating Downgrade)

Sep 22

RELX: Continues To Showcase Unfavorable Valuation

Jul 14

RELX Non-GAAP EPS of 102.2p, revenue of £8.55B

Feb 16

RELX: Consulting Appeal, But Only At A Good Price

Dec 11

RELX Is A Buy On Positive Outlook And Attractive Valuations

Sep 29

RELX 1H GAAP EPS, revenue up Y/Y

Aug 01

RELX: SaaS Industry's Future

Jul 15

RELX: Improving Performance Underlines Investment Case

Jan 29

RELX PLC: A Mixed Outlook

Sep 21

RELX: Better Times Coming

Jul 08

RELX goes ex-dividend tomorrow

Apr 28

RELX (RELX) Investor Presentation - Slideshow

Nov 18

Financial Position Analysis

Short Term Liabilities: RELX's short term assets (£2.7B) do not cover its short term liabilities (£5.6B).

Long Term Liabilities: RELX's short term assets (£2.7B) do not cover its long term liabilities (£6.0B).


Debt to Equity History and Analysis

Debt Level: RELX's net debt to equity ratio (210.2%) is considered high.

Reducing Debt: RELX's debt to equity ratio has reduced from 291.8% to 214.6% over the past 5 years.

Debt Coverage: RELX's debt is well covered by operating cash flow (37.1%).

Interest Coverage: RELX's interest payments on its debt are well covered by EBIT (9.5x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 23:06
End of Day Share Price 2024/12/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

RELX PLC is covered by 47 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Cor KluisABN AMRO Bank N.V.
Lionel PellicerAlphaValue
Ishan MajumdarBaptista Research